当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 现金流量表

傲农生物

(603363)

  

流通市值:81.82亿  总市值:133.27亿
流通股本:15.98亿   总股本:26.03亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,900,299,153.053,686,688,440.671,631,749,485.898,462,169,928.18
  收到其他与经营活动有关的现金283,053,682.97136,441,057.5259,605,919.151,141,271,709.93
  经营活动现金流入小计6,183,352,836.023,823,129,498.191,691,355,405.049,603,441,638.11
  购买商品、接受劳务支付的现金5,323,159,008.483,371,284,492.341,601,354,987.957,150,948,257.74
  支付给职工以及为职工支付的现金494,654,057.87330,378,349.39167,421,707.32861,818,847.55
  支付的各项税费62,069,045.4446,484,728.6130,711,913.3669,385,672.5
  支付其他与经营活动有关的现金594,939,318.38391,069,272.37237,720,684.11,638,070,095.17
  经营活动现金流出小计6,474,821,430.174,139,216,842.712,037,209,292.739,720,222,872.96
  经营活动产生的现金流量净额-291,468,594.15-316,087,344.52-345,853,887.69-116,781,234.85
二、投资活动产生的现金流量:
  收回投资收到的现金2,250,0002,250,0002,250,00028,149,656.2
  取得投资收益收到的现金1,087,228.9576,771.93-444,278.55
  处置固定资产、无形资产和其他长期资产收回的现金净额2,561,701.7344,121.7175,000164,815,255.79
  处置子公司及其他营业单位收到的现金净额56,132,093.2256,132,093.2250,196.7742,344,850.38
  收到的其他与投资活动有关的现金2,721,358.562,321,355.131,385,679.265,570,945.48
  投资活动现金流入小计64,752,382.4361,124,341.983,860,876.03241,324,986.4
  购建固定资产、无形资产和其他长期资产支付的现金182,595,112.43132,008,436.7790,142,165.06262,681,967.59
  投资支付的现金6,072,893.252,272,893.252,250,000-
  取得子公司及其他营业单位支付的现金389,574.83--2,100,000
  支付其他与投资活动有关的现金9,302,461.886,966,280.083,899,243.415,617,524.26
  投资活动现金流出小计198,360,042.39141,247,610.196,291,408.46280,399,491.85
  投资活动产生的现金流量净额-133,607,659.96-80,123,268.12-92,430,532.43-39,074,505.45
三、筹资活动产生的现金流量:
  吸收投资收到的现金18,044,32011,524,3206,094,6001,745,925,700
  其中:子公司吸收少数股东投资收到的现金18,044,32011,524,3206,094,60037,425,700
  取得借款收到的现金235,327,329.21193,840,329.2184,280,000524,032,662.04
  收到其他与筹资活动有关的现金48,823,162.474,146,0001,220,000438,418,478.67
  筹资活动现金流入小计302,194,811.68209,510,649.2191,594,6002,708,376,840.71
  偿还债务支付的现金318,091,161.36260,528,174.16106,347,086.18894,080,176.35
  分配股利、利润或偿付利息支付的现金53,765,626.5340,190,388.0112,782,034.11110,278,666.08
  其中:子公司支付给少数股东的股利、利润18,015,925.6913,795,147.993,412,00033,887,136.27
  支付其他与筹资活动有关的现金283,864,300.17195,205,147.2129,342,516.8568,528,076.24
  筹资活动现金流出小计655,721,088.06495,923,709.37248,471,637.091,572,886,918.67
  筹资活动产生的现金流量净额-353,526,276.38-286,413,060.16-156,877,037.091,135,489,922.04
四、汇率变动对现金及现金等价物的影响-19,425.38-6,984.71-2,391.124,437.98
五、现金及现金等价物净增加额-778,621,955.87-682,630,657.51-595,163,848.33979,638,619.72
  加:期初现金及现金等价物余额1,131,687,533.41,131,687,533.41,131,687,533.4152,048,913.68
  期末现金及现金等价物余额353,065,577.53449,056,875.89536,523,685.071,131,687,533.4
补充资料:
  净利润-375,393,633.1-63,091,581.34
  资产减值准备---137,651,322.86
  固定资产和投资性房地产折旧-199,699,465.03-587,349,350.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-199,699,465.03-587,349,350.99
  无形资产摊销-5,979,679.16-14,021,997.26
  长期待摊费用摊销-13,310,706.8-96,215,265.02
  处置固定资产、无形资产和其他长期资产的损失--270,002.62--46,159,637.47
  固定资产报废损失-206,211.33-40,571,644.73
  公允价值变动损失--37,140-26,859,346.21
  财务费用-67,585,902.75-655,469,320.99
  投资损失--372,837,359.85--1,529,647,328.52
  递延所得税--22,683,702.71-6,469,696.2
  其中:递延所得税资产减少--21,918,437.48-11,626,769.98
    递延所得税负债增加--765,265.23--5,157,073.78
  存货的减少--207,036,503.11-455,309,014.62
  经营性应收项目的减少--306,687,312.4--3,695,223,374.48
  经营性应付项目的增加--114,497,819.06-2,734,494,563.96
  其他--4,313,564.21-727,067.66
  债务转为资本-685,736,227.98-4,360,518,975.24
  现金的期末余额-449,056,875.89-1,131,687,533.4
  减:现金的期初余额-1,131,687,533.4-152,048,913.68
  现金及现金等价物的净增加额--682,630,657.51-979,638,619.72
公告日期2025-10-282025-08-262025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑